Equillium looking to battle unmet needs to treat severe autoimmune and inflammatory disorders

Equillium Inc CEO Bruce Steele joined Steve Darling from Proactive to talk more about the company that has a mission to develop therapeutics to treat severe autoimmune and inflammatory disorders.Steele talks more about the company’s proprietary multi-cytokine platform. Steele also talked about its pipeline and the numerous drugs in production.